US 12,239,711 B2
Cereblon ligands and bifunctional compounds comprising the same
Andrew P. Crew, Chester, CT (US); Craig M. Crews, New Haven, CT (US); Hanqing Dong, Madison, CT (US); Keith R. Hornberger, Southbury, CT (US); Yimin Qian, Plainsboro, NJ (US); Lawrence B. Snyder, Killingworth, CT (US); and Jing Wang, Milford, CT (US)
Assigned to Arvinas Operations, Inc., New Haven, CT (US)
Filed by Arvinas Operations, Inc., New Haven, CT (US)
Filed on Jan. 7, 2022, as Appl. No. 17/571,018.
Application 17/571,018 is a continuation of application No. 15/953,108, filed on Apr. 13, 2018, abandoned.
Application 15/953,108 is a continuation in part of application No. 14/792,414, filed on Jul. 6, 2015, abandoned.
Application 14/792,414 is a continuation in part of application No. 14/686,640, filed on Apr. 14, 2015, abandoned.
Claims priority of provisional application 62/171,090, filed on Jun. 4, 2015.
Claims priority of provisional application 61/979,351, filed on Apr. 14, 2014.
Prior Publication US 2023/0082997 A1, Mar. 16, 2023
Int. Cl. C07D 401/04 (2006.01); A61K 31/437 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01); A61K 47/54 (2017.01); A61K 47/55 (2017.01); A61P 35/00 (2006.01); C07D 401/14 (2006.01); C07D 471/04 (2006.01)
CPC A61K 47/55 (2017.08) [A61K 31/437 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 31/551 (2013.01); A61K 45/06 (2013.01); A61K 47/545 (2017.08); A61P 35/00 (2018.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 471/04 (2013.01)] 1 Claim
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.